Most of the symptoms people associate with the menopause transition announce themselves loudly. A hot flash arrives like weather. A 3 a.m. wake-up is hard to ignore. But there is a whole category of change that happens quietly, below the waist and below the threshold of polite conversation, and because no one warns you about it, you tend to assume it's just you.
It isn't. Vaginal dryness — along with burning, itching, discomfort during sex, and a sudden run of urinary tract infections after years of none — is one of the most common and least discussed parts of perimenopause and menopause. And unlike hot flashes, which often fade with time, this set of symptoms tends to get worse if nothing is done. Understanding why means understanding what estrogen was actually doing for tissue you never had to think about.
The tissue down there is estrogen-hungry
The vulva, vagina, urethra, and bladder trigone are dense with estrogen receptors. This is not incidental. Estrogen is what keeps that tissue thick, elastic, and well supplied with blood. It drives the production of glycogen in the vaginal lining, maintains a network of small blood vessels, and supports the natural lubrication that the vaginal walls produce continuously, not just during arousal.
When estrogen is plentiful — through your reproductive years — none of this requires your attention. The tissue is plump, folded into ridges called rugae that allow it to stretch, and naturally moist. As perimenopause sets in and estrogen levels begin their long, erratic decline, the supply to all those receptors drops. The lining thins. The rugae flatten. Blood flow decreases. The tissue becomes more fragile and less able to lubricate itself.
Clinicians have a name for the full picture: genitourinary syndrome of menopause, or GSM. The older term was "vaginal atrophy," which is accurate but bleak, and which also missed half the story — because the urinary tract is affected too. The newer name groups the vaginal and urinary symptoms together, because they share one cause.
Why the infections start
Here is the part that surprises people most. A stretch of recurrent UTIs in your late forties or fifties is often not bad luck or poor hygiene. It's the same estrogen story, told through your urinary tract.
That glycogen the vaginal lining produces under estrogen is food for lactobacilli, the beneficial bacteria that dominate a healthy vaginal microbiome. As they metabolize glycogen, they produce lactic acid, which keeps the vaginal environment acidic — a pH typically around 3.8 to 4.5. That acidity is protective. It crowds out the kind of bacteria, like E. coli, that cause urinary tract infections.
When estrogen falls, glycogen falls, the lactobacilli lose their food source, and their numbers drop. The pH rises and becomes more neutral. The protective acidic barrier weakens, and the environment becomes hospitable to exactly the organisms it used to repel. At the same time, the urethra and bladder lining — also estrogen-dependent — thin and become more vulnerable. The result is a tissue environment that is simply easier to infect. This is why some women find themselves cycling through antibiotics in midlife for the first time in their adult lives.
It rarely arrives all at once
GSM tends to creep. Early on it might be nothing more than a faint awareness that things feel different — a little less natural lubrication, a slight discomfort that you brush off. Months or years later it might be persistent dryness, itching or burning that has nothing to do with infection, spotting after sex because fragile tissue tears slightly, or a constant low-grade irritation.
The urinary side creeps too: a more urgent need to go, a feeling of not quite emptying, discomfort with urination, and those repeat infections. Because these changes are gradual and scattered across weeks, they're easy to attribute to anything else — a new soap, stress, a bad week, aging in the abstract. The slow pace is exactly what makes the pattern hard to see from the inside.
This is also why it differs from hot flashes in a way that matters. Vasomotor symptoms like flashes and night sweats often ease over a few years as the body recalibrates. GSM does the opposite. Because it's driven by a sustained absence of estrogen rather than the chaotic fluctuations of early perimenopause, it tends to persist and progress after the final period. Left alone, it usually doesn't resolve on its own.
What actually helps — and what the science says
The encouraging part is that GSM responds well to treatment, often better than the more dramatic symptoms do. There are two broad categories, and they work differently.
Non-hormonal options address comfort directly. Vaginal moisturizers — used regularly, not just before sex — are absorbed into the tissue and help it hold water over time; they're different from lubricants, which reduce friction in the moment. Both have a role, and for milder dryness they can be enough.
For the underlying tissue change, local estrogen is the treatment most directly aimed at the cause. Delivered as a low-dose cream, tablet, or ring placed vaginally, it restores estrogen to the receptors in that tissue specifically. Over weeks, the lining thickens again, blood flow improves, glycogen returns, the lactobacilli recover, and the pH drops back toward its protective range — which is also why local estrogen is well established for reducing recurrent UTIs in postmenopausal women. Because the dose is low and the effect is largely local, its systemic absorption is minimal, which is part of why major menopause societies regard it as appropriate even for many women who can't or don't want to take systemic hormone therapy. These are decisions to make with a clinician who knows your history, but the point is that effective, well-studied options exist. This is not something you simply have to live with.
Why naming it changes the appointment
The biggest obstacle to treatment is usually that the subject never comes up. Surveys consistently find that most women with these symptoms never raise them with a doctor, and many doctors don't ask. Embarrassment plays a role. So does the quiet assumption that this is simply what aging feels like and nothing can be done. The symptom that hides best is the one that gets the least help.
This is where paying attention pays off. When the dryness, the discomfort, the irritation, and the urinary changes are noticed as scattered, unrelated annoyances, they're easy to dismiss one by one. Seen together, plotted over months, they form an obvious pattern — the signature of GSM — and that pattern is precisely what lets you walk into an appointment and name the thing instead of hoping the doctor guesses. A clear account of when the dryness started, how often the infections recur, and how it tracks against your changing cycle turns a vague, awkward complaint into a specific clinical conversation.
That's the quiet case for keeping a record. MenoTrack is a privacy-first symptom tracker built for exactly this kind of slow, scattered change — the symptoms that are easy to feel and hard to see whole, the ones you'd rather not put in someone else's cloud. Logging dryness, discomfort, and urinary symptoms alongside everything else lets the pattern surface on its own, so that when you sit down with a clinician you're describing a documented trend, not a hazy impression. If you've been quietly wondering whether it's just you, it isn't — and you can start seeing the shape of it at https://menotrack.lumenlabs.works.